Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension.

Q1 Medicine Interventional Neurology Pub Date : 2020-01-01 Epub Date: 2019-06-04 DOI:10.1159/000500051
Fawaz Al-Mufti, Vincent Dodson, Krishna Amuluru, Jessy Walia, Ethan Wajswol, Rolla Nuoman, Irwin A Keller, Steven Schonfeld, Sudipta Roychowdhury, Gaurav Gupta
{"title":"Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension.","authors":"Fawaz Al-Mufti,&nbsp;Vincent Dodson,&nbsp;Krishna Amuluru,&nbsp;Jessy Walia,&nbsp;Ethan Wajswol,&nbsp;Rolla Nuoman,&nbsp;Irwin A Keller,&nbsp;Steven Schonfeld,&nbsp;Sudipta Roychowdhury,&nbsp;Gaurav Gupta","doi":"10.1159/000500051","DOIUrl":null,"url":null,"abstract":"<p><p>Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients (<i>n</i> = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy.</p>","PeriodicalId":46280,"journal":{"name":"Interventional Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000500051","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000500051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/6/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 15

Abstract

Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients (n = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
特发性颅内高压的神经血管内脑窦支架植入术。
特发性颅内高压(IIH)是一种罕见的、发病率高的疾病。由于病理生理学知之甚少,治疗方案不统一,并针对减轻最常见的症状:头痛和视力丧失。在这篇综述中,我们分析了25个病例系列,其中包括接受静脉窦支架置入治疗的IIH患者(n = 408)。在342例头痛患者中,240例(70.2%)患者在支架置入后头痛得到改善或缓解。在217例有视力问题的患者中,161例(74.2%)患者的视力得到改善或稳定。304例乳头水肿患者中,257例(84.5%)得到缓解或改善。在124例出现搏动性耳鸣的患者中,110例(88.7%)患者在支架置入术后耳鸣得到缓解。因此,硬脑膜窦狭窄的血管内治疗对于内科和外科治疗失败的IIH患者是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Interventional Neurology
Interventional Neurology CLINICAL NEUROLOGY-
自引率
0.00%
发文量
0
期刊最新文献
Recanalization of Tandem Vertebrobasilar Occlusions with Contralateral Vertebral Occlusion or Hypoplasia via either Direct Passage or the SHERPA Technique. Does the Addition of Non-Approved Inclusion and Exclusion Criteria for rtPA Impact Treatment Rates? Findings in Australia, the UK, and the USA. In vitro Remote Aspiration Embolectomy for the Treatment of Acute Ischemic Stroke. Endovascular Reperfusion for Acute Isolated Cervical Carotid Occlusions: The Concept of "Hemodynamic Thrombectomy". An Appraisal of the 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1